Insider to sell 23,906 Common shares — Cytokinetics (NASDAQ: CYTK)
Rhea-AI Filing Summary
Insider filing to sell Common stock. The Form 144 lists 23,906 Common shares tied to restricted stock units and performance stock units dated 12/03/2024. The filing records a prior sale of 4,935 shares on 03/17/2026 for $306,710.25. The broker shown is Morgan Stanley Smith Barney LLC.
Positive
- None.
Negative
- None.
Insights
Form 144 notifies the market of an intended sale of issuer stock by an affiliate.
Form 144 is a notice of proposed sale under securities rules. This filing lists 23,906 Common shares to be sold that are associated with restricted stock units and performance stock units dated 12/03/2024, and shows a past sale of 4,935 shares on 03/17/2026 for $306,710.25. The broker identified is Morgan Stanley Smith Barney LLC.
The filing itself is administrative and does not state timing or whether sales will proceed. Subsequent SEC filings (or trade reporting) would show executed transactions and exact proceeds.